CA2759442C - Galactooligosaccharide for use in prevention of intestinal inflammatory disorder - Google Patents

Galactooligosaccharide for use in prevention of intestinal inflammatory disorder Download PDF

Info

Publication number
CA2759442C
CA2759442C CA2759442A CA2759442A CA2759442C CA 2759442 C CA2759442 C CA 2759442C CA 2759442 A CA2759442 A CA 2759442A CA 2759442 A CA2759442 A CA 2759442A CA 2759442 C CA2759442 C CA 2759442C
Authority
CA
Canada
Prior art keywords
gal
beta
galactooligosaccharide
cells
gos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2759442A
Other languages
English (en)
French (fr)
Other versions
CA2759442A1 (en
Inventor
Georgios Tzortzis
Jelena Vulevic
Francesco Attanasio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clasado Ltd
Original Assignee
Clasado Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40774842&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2759442(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Clasado Inc filed Critical Clasado Inc
Publication of CA2759442A1 publication Critical patent/CA2759442A1/en
Application granted granted Critical
Publication of CA2759442C publication Critical patent/CA2759442C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
CA2759442A 2009-04-23 2010-04-23 Galactooligosaccharide for use in prevention of intestinal inflammatory disorder Active CA2759442C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0906983.2 2009-04-23
GBGB0906983.2A GB0906983D0 (en) 2009-04-23 2009-04-23 Novel use
GB0920784.6 2009-11-27
GBGB0920784.6A GB0920784D0 (en) 2009-04-23 2009-11-27 Novel use
PCT/GB2010/050659 WO2010122344A1 (en) 2009-04-23 2010-04-23 Novel use

Publications (2)

Publication Number Publication Date
CA2759442A1 CA2759442A1 (en) 2010-10-28
CA2759442C true CA2759442C (en) 2016-01-19

Family

ID=40774842

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2759442A Active CA2759442C (en) 2009-04-23 2010-04-23 Galactooligosaccharide for use in prevention of intestinal inflammatory disorder

Country Status (25)

Country Link
US (1) US20120058972A1 (enExample)
EP (1) EP2421541B1 (enExample)
JP (1) JP2012524770A (enExample)
KR (1) KR20110138416A (enExample)
CN (1) CN102427818A (enExample)
AU (1) AU2010240642B2 (enExample)
BR (1) BRPI1015091A2 (enExample)
CA (1) CA2759442C (enExample)
CY (1) CY1120597T1 (enExample)
DK (1) DK2421541T3 (enExample)
ES (1) ES2688786T3 (enExample)
GB (3) GB0906983D0 (enExample)
HU (1) HUE040451T2 (enExample)
IL (1) IL215855A0 (enExample)
MX (1) MX341308B (enExample)
MY (1) MY151104A (enExample)
NZ (1) NZ595969A (enExample)
PL (1) PL2421541T3 (enExample)
PT (1) PT2421541T (enExample)
RU (1) RU2530567C2 (enExample)
SG (1) SG175313A1 (enExample)
TR (1) TR201810868T4 (enExample)
UA (1) UA106491C2 (enExample)
WO (1) WO2010122344A1 (enExample)
ZA (1) ZA201107821B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2492559B (en) * 2011-07-05 2018-07-25 Clasado Inc Composition and method for preventing or reducing the risk of developing a syndrome
BR112014001472A2 (pt) 2011-07-22 2017-02-21 Abbott Lab galactooligossacarídeos para prevenir lesões e / ou promover a cicatrização do trato gastrointestinal
CN103716787B (zh) 2012-09-29 2020-06-23 北京三星通信技术研究有限公司 一种支持对家用基站进行验证的方法
CA2983236A1 (en) 2015-04-23 2016-10-27 Kaleido Biosciences, Inc. Glycan therapeutics and methods of treatment
CN107158011A (zh) * 2017-05-25 2017-09-15 浙江大学 低聚半乳糖在制备治疗肠道疾病的药物中的用途
BR112021022447A2 (pt) * 2019-05-15 2021-12-28 Nutricia Nv Métodos para aumentar a função da barreira intestinal e/ou para a prevenção e/ou o tratamento de ruptura da barreira intestinal, método para o tratamento, a prevenção e/ou o alívio de uma condição associado à exposição a toxinas, fórmula infantil, fórmula de seguimento ou fórmula para criança de primeira infância, trissacarídeos, composições nutricionais, uso do trissacarídeo e usos de uma composição nutricional
US20240277739A1 (en) * 2021-07-01 2024-08-22 N.V. Nutricia Nutritonal compositions for gut barrier function
KR102453998B1 (ko) * 2022-01-07 2022-10-14 (주)네오크레마 갈락토올리고당을 포함하는 염증성 장질환의 예방, 개선 또는 치료용 조성물
GB2619977A (en) * 2022-06-24 2023-12-27 Clasado Res Services Limited Compositions and uses thereof
GB2623336A (en) * 2022-10-12 2024-04-17 Clasado Res Services Limited Compositions and uses thereof
GB2623335A (en) * 2022-10-12 2024-04-17 Clasado Res Services Limited Compositions and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0229015D0 (en) * 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
GB0315266D0 (en) * 2003-06-30 2003-08-06 Clasado Inc Novel galactooligosaccharide composition and the preparation thereof
EP1644482B2 (en) * 2003-06-30 2014-10-01 Clasado Inc. Novel galactooligosaccharide composition and the preparation thereof
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
EP1887017A1 (en) * 2006-08-09 2008-02-13 Friesland Brands B.V. Prebiotic carbohydrate
GB0809921D0 (en) * 2008-05-30 2008-07-09 Clasado Inc Product and process therefor

Also Published As

Publication number Publication date
EP2421541A1 (en) 2012-02-29
HUE040451T2 (hu) 2019-03-28
GB2482817B (en) 2014-02-26
KR20110138416A (ko) 2011-12-27
RU2530567C2 (ru) 2014-10-10
NZ595969A (en) 2013-03-28
WO2010122344A1 (en) 2010-10-28
PT2421541T (pt) 2018-10-15
CY1120597T1 (el) 2019-12-11
CA2759442A1 (en) 2010-10-28
SG175313A1 (en) 2011-11-28
GB201120030D0 (en) 2012-01-04
TR201810868T4 (tr) 2018-08-27
IL215855A0 (en) 2012-01-31
MY151104A (en) 2014-04-15
EP2421541B1 (en) 2018-07-11
ZA201107821B (en) 2012-07-25
AU2010240642A1 (en) 2011-11-10
PL2421541T3 (pl) 2018-11-30
CN102427818A (zh) 2012-04-25
GB0920784D0 (en) 2010-01-13
AU2010240642B2 (en) 2013-03-14
ES2688786T3 (es) 2018-11-06
GB2482817A (en) 2012-02-15
JP2012524770A (ja) 2012-10-18
MX341308B (es) 2016-08-12
DK2421541T3 (en) 2018-09-24
UA106491C2 (uk) 2014-09-10
BRPI1015091A2 (pt) 2016-04-26
GB0906983D0 (en) 2009-06-03
US20120058972A1 (en) 2012-03-08
RU2011147390A (ru) 2013-05-27
MX2011011159A (es) 2011-11-07

Similar Documents

Publication Publication Date Title
CA2759442C (en) Galactooligosaccharide for use in prevention of intestinal inflammatory disorder
CA2724766A1 (en) Use of prebiotic galacto-oligosaccharides in the treatment of intestinal inflammation
Nijman et al. Characterization and quantification of oligosaccharides in human milk and infant formula
Li et al. Stachyose-enriched α-galacto-oligosaccharides regulate gut microbiota and relieve constipation in mice
Hernot et al. In vitro fermentation profiles, gas production rates, and microbiota modulation as affected by certain fructans, galactooligosaccharides, and polydextrose
JP2021063079A (ja) グリカン治療剤及びその関連方法
US20240309408A1 (en) Methods of Use of Oligosaccharide Compositions for Modulating Microbiota and their Metabolic Products, and as Therapeutics for Health Applications
RU2469558C2 (ru) Применение пробиотиков и волокон при диарее
EP3165227A1 (en) Composition for treating or preventing metabolic disease, containing, as active ingredient, extracellular vesicles derived from akkermansia muciniphila bacteria
CN102670662A (zh) 糖醛酸和益生菌
CN107771083A (zh) 聚糖治疗剂和治疗方法
WO2011005681A1 (en) Inhibiting inflammation with milk oligosaccharides
NZ264517A (en) An antiulcer agent comprising fucoidan as adhesion inhibitor
Diez-Municio et al. Efficient synthesis and characterization of lactulosucrose by Leuconostoc mesenteroides B-512F dextransucrase
WO2023220318A2 (en) Methods for treating urogenital health conditions
Macfarlane et al. Food and the large intestine
CN101372679B (zh) 一种双歧双歧杆菌菌株及其使用方法
KR102000714B1 (ko) 전호 잎 유래 루테올린 7-o-(6″-말로닐글루코사이드)를 유효성분으로 포함하는 관절염 및 자가면역질환의 예방 또는 치료용 조성물
Ambrogi et al. Bifidobacterial ß-galactosidase-mediated production of galacto-oligosaccharides: structural and preliminary functional assessments
Spence et al. Digestive Disease Week 2020
Fellin Spence et al. Digestive Disease Week 2020. Virtual Meeting-May 2020
TW202333752A (zh) 以外多醣治療睡眠障礙之方法
KR20240053740A (ko) 인간 모유 올리고당 및 베타-글루칸이 포함된 장기능 개선용 조성물
Ambrogi et al. β-Galactosidase-Mediated Production of Galacto-Oligosaccharides: Structural and Preliminary Functional Assessments
Garleb et al. Application of fructooligosaccharides to medical foods as a fermentable dietary fiber

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20130215